The European pharmaceutical industry federation EFPIA has called for the introduction of a “transferable exclusivity extension” as an incentive to encourage companies to invest in the development of new products to tackle antimicrobial resistance (AMR), which it says could easily be implemented via EU legislation.
European Industry Proposes Incentive To Develop New Antimicrobials
EFPIA Urges Care Over Definition Of ‘Unmet Medical Need’
With proposals for an overhaul of the EU medicines legislation due at the end of this year, EFPIA has published its formal response to the European Commission’s consultation with suggestions for facilitating new antibiotic development, testing new regulatory approaches to novel medicines, and tackling medicine shortages.
